MHC Class II IA β Chain (58-75)结构式
|
常用名 | MHC Class II IA β Chain (58-75) | 英文名 | MHC Class II IA β Chain (58-75) |
|---|---|---|---|---|
| CAS号 | 157505-54-9 | 分子量 | 2276.414 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C100H150N26O35 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-Acetyl-L-alanyl-L-α-glutamyl-L-tyrosyl-L-tyrosyl-L-asparaginyl-L-lysyl-L-glutaminyl-L-tyrosyl-L-leucyl-L-α-glutamyl-L-glutaminyl-L-threonyl-L-arginyl-L-alanyl-L-α-glutamyl-L-leucyl-L-alpha-aspartyl-L-threoninamide |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 分子式 | C100H150N26O35 |
| 分子量 | 2276.414 |
| 精确质量 | 2275.075684 |
| LogP | -6.05 |
| 折射率 | 1.659 |
|
A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis.
Proc. Natl. Acad. Sci. U. S. A. 91 , 8005, (1994) Experimental autoimmune encephalomyelitis (EAE) is a class II major histocompatibility complex (MHC)-restricted, T-cell-mediated, demyelinating autoimmune disease of the central nervous system and rep... |
| L-Threoninamide, N-acetyl-L-alanyl-L-α-glutamyl-L-tyrosyl-L-tyrosyl-L-asparaginyl-L-lysyl-L-glutaminyl-L-tyrosyl-L-leucyl-L-α-glutamyl-L-glutaminyl-L-threonyl-L-arginyl-L-alanyl-L-α-glutam
 yl-L-leucyl-L-α-aspartyl- |
| N-Acetyl-L-alanyl-L-α-glutamyl-L-tyrosyl-L-tyrosyl-L-asparaginyl-L-lysyl-L-glutaminyl-L-tyrosyl-L-leucyl-L-α-glutamyl-L-glutaminyl-L-threonyl-L-arginyl-L-alanyl-L-α-glutamyl-L-leucyl-L-alp
 ha-aspartyl-L-threoninamide |
